Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected

Abstract

Efavirenz and didanosine exposure during pregnancy were associated with higher risk of neurologic abnormalities in CHEU, and dolutegravir exposure showed some suggestive associations, which warrant further monitoring.